A new Alcon-sponsored survey conducted by Wakefield Research uncovered a gap between parental recognition of the role of ...

Key opportunities in the ophthalmology devices market include the rising demand for minimally invasive surgeries, innovation ...

Key Points Interested in RxSight, Inc.? Here are five stocks we like better. RxSight's preliminary Q2 sales fell 20% year ...

Alcon (SWX:ALC) shares are in focus after the company agreed a non exclusive collaboration with RxSight to co develop ...

Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...

On June 26, 2026, Chancellor Kathaleen St. J. McCormick of the Delaware Court of Chancery dismissed derivative claims against certain directors and stockholders on behalf of a biotech company (the ...

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL ...

When you spot an item you love on social media or while out and about, Amazon Lens is the quickest way to find similar items in the Amazon Shopping app. Now, we’re making Amazon Lens even better with ...

Alcon’s ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming quarters. However, adverse macroeconomic conditions and intense competition may ...

Live News Alcon AG Analyst Outlook - macroeconomic data, inflation trends, and interest rates tracking. Some traders rely on ...

A Delaware judge dismissed a former Aurion Biotech executive's challenge to a stockholder's alleged takeover of the company, ...